About perioperativebleeding.org

Our project www.perioperativebleeding.org (POB) aims to provide physicians world-wide with clinically useful and most up-to-date information concerning the diagnosis and treatment of perioperative bleeding situations. This project was designed in 2009 for anaesthesiologists, haematologists and allied health professionals who manage, treat or refer patients in the field of perioperative bleeding management. Distinguished lectures in this field recorded at scientific meetings are presented in a multimedia audio-visual display (text slides plus audio track). Our academic, educational and non-profit platform will be supplemented periodically by amendments with upcoming lectures.

What makes POB unique is the

  • primary academic mission
  • presentation of interdisciplinary and international management approaches without the dictate of state-of-the-art care
  • innovative multimedia display of lectures
  • Continuing Medical Education (CME) accreditation online without costly membership fees
  • distance learning course to improve decision-making skills

About the lectures

Text slides plus audio tracks of the speaker's lectures are available free of charge after logging in. Relevant material is collected starting in 2007.

About CME

World-wide learning

Double-loop learning with verifiable success is a prerequisite for licensing requirements and Continuing Medical Education (CME) credits. Our educational platform POB offers physicians around the world the opportunity of earning CME points online by working through a module, which consists of a lecture in our virtual symposium, and correctly answering the multiple choice questions, which focus on the hosted lecture. Access to our educational platform POB is reserved for healthcare professionals and CME accreditation requires a personalised login.

Process of acquiring a CME credit

The number of CME points to be earned by the expiry date is indicated for each module at the upper right corner of the module box. To complete this activity, listen to the lecture in its entirety, go to the link provided at the end of the activity to complete the evaluation, take the multiple choice test and download/print the CME certificate(s). The learner should expect that it takes one hour in order to fulfil the requirement for one CME credit.

The quality of the content is in accordance with Austrian regulations for CME certification by the Österreichische Ärzteakademie (ÖÄK) . Personalised CME certificates will be issued after passing the multiple choice test.

The icon for specific lectures indicates European CME credits (ECMEC) to be earned from the European certifying authority European Accreditation Council for Continuing Medical Education (EACCME) which is an institution of the European Union of Medical Specialists (UEMS).

CME credits issued will either be accepted directly by your local medical authority or can be converted in accordance with your local legal requirements.

Process of CME credit conversion to AMA PRA Category 1 credits
EACCME approved credits (ECMEC) are recognised by the American Medical Association for conversion to AMA PRA Category 1 Credit™ (www.uems.net). Physicians may apply to convert an EACCME credit into an AMA PRA Category 1 Credit™ by submitting an application form for EACCME Credit Conversion (http://www.ama-assn.org/ama/pub/education-careers/continuing-medical-education/cme-forms.shtml) and attaching an EACCME credit certificate and processing fee (payable to the American Medical Association: AMA members $30, Non-AMA member $75). Mail or fax these files to the American Medical Association, CPPD, 515 North State Street, 7th Floor, Chicago, IL 60654 (Fax: 312-464-5129. If you have any questions or concerns, please call 312-464-5296). A certificate of AMA PRA Category 1 Credit™ will be mailed within 4 weeks.

About the scientific board

Our platform POB has been created by an interdisciplinary group of clinicians with a deep interest in perioperative bleeding management. High academic standards of our educational platform POB are ensured by our board members. The founder members are anaesthesiologists, a haematologist and lab physician, and an anaesthesiologist and pharmacologist. It took one year from the initial spark in summer 2008 to the launch in summer 2009.

Our Team

Prof. Dr. Sibylle Kietaibl (formerly Kozek-Langenecker), MBA
Professor and Chairwoman, Department of Anaesthesia and Intensive Care, Evangelisches Krankenhaus Vienna, Vienna Austria

She is Professor in Anaesthesiology and Intensive Care, president past of the Austrian Society of Anesthesiology, Resuscitation and Intensive Care (ÖGARI), former chairwoman of the Task Force on Perioperative Coagulation of the ÖGARI, former chairwoman of the subcommittee 6 Transfusion and Haemostasis of the European Society of Anesthesiology (ESA), member of the ESA Guideline Committee, delegate of the ÖGARI at the European Board of Anaesthesiology (EBA), and member of the scientific committee of the Network for the Advancement of Transfusion Alternatives (NATA). She is an examiner for the Austrian examination for anaesthesiologists and has a keen interest in the training of undergraduates and postgraduates in anaesthesiology at the Vienna Medical University. Her main area of research is praeoperative evaluation and optimisation, platelet function monitoring, intraoperative point-of-care (POC) coagulation monitoring and the POC-guided treatment algorithm, and fluid management. She has published widely on these subjects and she serves on the editorial board of Anesthesiology Research & Practice (Section Transfusion), Anästhesie, Intensivmedizin, Notfallmedizin und Schmerz AINS and as a reviewer for many journals in the areas of anaesthesiology and haemostasis.

Disclosure statement: Dr. Kietaibl has disclosed that she has received honoraria as a speaker and research support from the following commercial organisations: Astra Zeneca, Baxter, B.Braun, Biotest, CSL Behring, Dynabyte, Ekomed, Fresenius Kabi, GlaxoSmithKline, Mitsubishi Pharma, NovoNordisk, Octapharma, Pentapharm.

Prof. Hugh C. Hemmings, Jr., M.D., Ph.D.
Departments of Anesthesiology and Pharmacology Weill Medical College of Cornell University, New York, U.S.A.

Dr. Hemmings's research interests include the neuropharmacology of general anaesthetics and neuronal cell signalling. His clinical interests include thoracic anaesthesia, neuroanaesthesia and novel approaches to analgesia. He is co-editor of the textbook "Foundations of Anesthesia". He is an Editor of Anesthesiology and of the British Journal of Anaesthesia.

Conflicts of Interest: Dr. Hemmings has served as a consultant for Abbott, Biowave, Cadence, CSL Behring and Skye-Pharma, and has received research support from Biowave and NIH.

Prof. Charles-Marc Samama, MD, PhD, FCCP
Professor and Chairman, Department of Anaesthesia and Intensive Care of Cochin University Hospital in Paris, France

Charles Marc Samama is 57 yo. He is currently Professor and Chairman in the Department of Anaesthesia and Intensive Care of Cochin University Hospital in Paris, France. He also heads a laboratory in the INSERM 1140 research unit and for many years, he has developed an experimental model of arterial thrombosis and bleeding in the rabbit.

Professor Samama is the Chair-Elect of of the Scientific Committee of the European Society of Anaesthesiology (ESA). He also co-chairs the Scientific Standardization Committee on Predictive Variables in Cardiovascular Disease of the International the Society on Thrombosis and Haemostasis (ISTH). He is also co-chairing the new Perioperative Thrombosis and Hemostasis Working Group of the ISTH.

He has published more than 160 peer-reviewed articles and reviews and has directed the French Guidelines on Perioperative Venous Thromboembolism (VTE) Prophylaxis. He has co-authored the VTE prevention section of Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines 8th edition (“Prevention of venous thromboembolism”) and 9th edition (“Prevention in VTE in non-orthopaedic surgical patients”). He has co-authored the 2013 ESA Guidelines on Management of severe perioperative bleeding.

Dr. Samama received unrestricted grants for experimental animal studies and medical writing from LFB, NovoNordisk and CSL Behring. He received consultant fees from AstraZeneca, Boehringer-Ingelheim, Daiichi-Sankyo, Sanofi-Aventis, GSK, Pfizer and BMS, and he was on the advisory board of Bayer, Haemonetics and Roche.

Prof. Dr. Donat R. Spahn
Institute of Anaesthesiology, University Hospital Zurich, Zurich, Switzerland

Dr. Spahn is Professor and Chairman of the Institute of Anaesthesiology at the University Hospital Zurich, Switzerland. He received his medical degrees from Zurich University and undertook his residency in anaesthesia and surgery in Aarau, Baden an Zurich, Switzerland. He trained in Cardiac Anaesthesia in the Department of Anaesthesiology, Division of Cardiac Anaesthesia, in the Heart Centre at Duke, Duke University Medical Centre, Durham, North Carolina.

Dr. Spahn's current areas of interest include perioperative risk assessment and cardioprotection, praeconditioning and organ protection, pulmonary and renal physiology, oxygen transport, blood transfusion and alternatives including praeoperative anaemia treatment, artificial oxygen carriers, anaemia tolerance, crystalloid and colloid therapy, blood coagulation, physiology of cardiopulmonary bypass, perioperative monitoring and pain. In addition, he is heavily involved in postgraduate training and (CME-credited) education. His clinical interests are in the perioperative treatment of high risk surgical patients and the implementation of Patient Blood Management. He has served on the editorial board of several scientific journals and has published over 290 articles in well-known international scientific journals.

Conflicts of Interest: Dr. Spahn's academic department is currently receiving grant support from the University of Zurich, the Research Award Centre for Zurich Integrative Human Physiology, the Swiss National Science Foundation, the Swiss Foundation for Anesthesia Research, the European Society of Anaesthesiology (ESA), the Swiss Society of Anaesthesiology and Reanimation (SGAR), the Gebert Ruef Foundation, the Swiss Life Foundation, the Olga Mayenfisch Foundation, Abbott AG, Switzerland and B. Braun, Switzerland, UBS, Switzerland, Stiftung für Staublungenforschung, Switzerland. Dr. Spahn is chairman of the ABC Faculty and a member of the ABC Trauma Faculty which are both managed by Thomson Physicians World GmbH, Mannheim, Germany and sponsored by an unrestricted educational grant from Novo Nordisk A/S, Bagsvärd, Denmark. In addition, in the past 5 years, Dr. Spahn has received honoraria or travel support for consulting or lecturing from the following companies: Abbott AG, Baar, Switzerland, Alliance Pharmaceutical Corp., San Diego, California, USA, AstraZeneca AG, Zug, Switzerland, Bayer (Schweiz) AG, Zürich, Switzerland, B. Braun Melsungen AG, Melsungen, Germany, Boehringer Ingelheim (Schweiz) GmbH, Basel, Switzerland, CSL Behring GmbH, Hattersheim am Main, Germany, Fresenius SE, Bad Homburg v.d.H., Germany, Galenica AG, Bern, Switzerland (including Vifor SA, Villars-sur-Glâne, Switzerland), GlaxoSmithKline GmbH & Co. KG, Hamburg, Germany, Janssen-Cilag AG, Baar, Switzerland, Novo Nordisk A/S, Bagsvärd, Denmark, Octapharma AG, Lachen, Switzerland, Organon AG, Pfäffikon/SZ, Switzerland, Oxygen Biotherapeutics, Costa Mesa, CA, and Roche Pharma (Schweiz) AG, Reinach, Switzerland.

Assoc. Prof. Kenichi Tanaka, M.D.
Department of Anesthesiology, Emory University School of Medicine, Atlanta, U.S.A.

Dr. Tanaka is Associate Professor of Anaesthesiology, Emory University School of Medicine, and a member of Association of University Anesthesiologists (AUA). He serves on the Committee on Blood Management for American Society of Anesthesiologists (ASA), and the Research Committee of Society of Cardiovascular Anesthesiologists (SCA). His field of research includes clinical perioperative haemostatic management, anticoagulant therapy, antifibrinolytic therapy, thromboelastography/metry as well as in vitro and computer-based modelling of thrombin generation. He regularly serves as a reviewer for Anesthesia & Analgesia, and other peer-reviewed anaesthesiology and haematology journals.

Disclosure statement: Dr. Tanaka has disclosed that he has previously received honoraria as a speaker for Bayer, and CSL Behring, and has received research support from the following commercial organisations: Bayer, CSL Behring, Eagle, and Regado.

Prof. Dr. Karim Brohi
Surgeon Trauma Clinical Academic Unit, The Royal London Hospital, London, UK

Dr. Brohi is Professor of Trauma Sciences at Barts and the London School of Medicine & Dentistry, and consultant in trauma & vascular surgery at The Royal London Hospital. He attended medical school at University College London and received training in London, Oxford, Cape Town and the San Francisco General Hospital. He leads active research programmes in basic, translational and clinical trauma science at Barts and the London Hospital and he has been engaged in collaborations throughout the world. A central interest of his includes coagulation and inflammation activation following injury, which is supported by a grant from the National Institute of Health Research. Brohi is the founder of the Trauma.org web site and Trauma-list email discussion group, which are both now in their 11th year of existence. He has lectured widely around the world and is committed to world-wide access to free, high quality education in trauma care.

Disclosure statement: Dr. Brohi received unrestricted research funding in terms of equipment and reagents from Pentapharm and Dynabyte.